Avadel Pharmaceuticals (AVDL) Other Working Capital Changes: 2009-2024
Historic Other Working Capital Changes for Avadel Pharmaceuticals (AVDL) over the last 16 years, with Dec 2024 value amounting to -$828,000.
- Avadel Pharmaceuticals' Other Working Capital Changes fell 300100.00% to -$3.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$30.9 million, marking a year-over-year decrease of 3033.65%. This contributed to the annual value of -$828,000 for FY2024, which is 138.42% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Other Working Capital Changes stood at -$828,000 for FY2024, which was down 138.42% from $2.2 million recorded in FY2023.
- Avadel Pharmaceuticals' 5-year Other Working Capital Changes high stood at $2.2 million for FY2023, and its period low was -$30.9 million during FY2022.
- Its 3-year average for Other Working Capital Changes is -$9.9 million, with a median of -$828,000 in 2024.
- Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 156.63% in 2021, then tumbled by 3,033.65% in 2022.
- Over the past 5 years, Avadel Pharmaceuticals' Other Working Capital Changes (Yearly) stood at -$1.9 million in 2020, then surged by 156.63% to $1.1 million in 2021, then slumped by 3,033.65% to -$30.9 million in 2022, then spiked by 106.96% to $2.2 million in 2023, then tumbled by 138.42% to -$828,000 in 2024.